Nuclear Medicine Application of Pentixafor/Pentixather Targeting CXCR4 for Imaging and Therapy in Related Disease
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
23
Page:
787-803
Author(s):
Zhenying Chen, Qianqian Xue and Shaobo Yao*
Involvement of Metabolites and Non-coding RNAs in Diseases
Journal:
Current Pharmaceutical Biotechnology
Volume:
24
Page:
889-912
Author(s):
Kubra A. Coskun, Bercem Yeman Kıyak, Kezban Ucar Cifci, Elif Kadioglu, Nazlican Yurekli and Yusuf Tutar*
MicroRNAs and Long Non-coding RNAs as Novel Targets in Anti-cancer Drug Development
Journal:
Current Pharmaceutical Biotechnology
Volume:
24
Page:
913-925
Author(s):
Melisa Çetinkaya and Yusuf Baran*
Targeting T Cell Metabolism as a Novel Approach for Treatment of MS: With a Focus on PFKFB3 Inhibitors
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
23
Page:
417-422
Author(s):
Mahsa Eshkevar Vakili, Fateme Nezhad Shah Mohammadi, Mohammad Reza Ataollahi, Keivan Shams, Kari K. Eklund, Gholamreza Daryabor and Kurosh Kalantar*
Marine-derived Natural Products as Anticancer Agents
Journal:
Medicinal Chemistry
Volume:
19
Page:
538-555
Author(s):
Nancy Saini, Ritika Sirohi, Anuradha A., Neetu Saini, Pankaj Wadhwa, Paranjeet Kaur, Vikas Sharma, Gurdeep Singh, Iqubal Singh and Sanjeev Kumar Sahu*
Diagnosis and Clinical Aspects of Lung Cancer: A Special Emphasis on Drug Targeting to Cancer Cells through Nanoparticles
Journal:
Letters in Drug Design & Discovery
Volume:
20
Page:
499-516
Author(s):
Rajendra Awasthi*, Anurag Kumar Singh, Gaurav Mishra, Anand Maurya, Neerupma Dhiman, Harsha Kharkwal, Bhupesh Sharma, Niraj Kumar Jha, Harish Dureja, Kamal Dua, Terezinha de Jesus Andreoli Pinto and Giriraj T. Kulkarni
Combination Therapy of Chemotherapy or Radiotherapy and the Neurokinin-1 Receptor Antagonist Aprepitant: A New Antitumor Strategy?
Journal:
Current Medicinal Chemistry
Volume:
30
Page:
1798-1812
Author(s):
Prema Robinson*, Rafael Coveñas and Miguel Muñoz*
Resveratrol Augments Doxorubicin and Cisplatin Chemotherapy: A Novel Therapeutic Strategy
Journal:
Current Molecular Pharmacology
Volume:
16
Page:
280-306
Author(s):
Sepideh Mirzaei, Mohammad Hossein Gholami, Amirhossein Zabolian, Hossein Saleki, Morteza Bagherian, Seyed Mohammadreza Torabi, Seyed Omid Sharifzadeh, Kiavash Hushmandi, Kaila R. Fives, Haroon Khan, Milad Ashrafizadeh, Ali Zarrabi* and Anupam Bishayee*
Fighting Carcinogenesis with Plant Metabolites by Weakening Proliferative Signaling and Disabling Replicative Immortality Networks of Rapidly Dividing and Invading Cancerous Cells
Journal:
Current Drug Delivery
Volume:
20
Page:
371-386
Author(s):
Atif Khurshid Wani, Nahid Akhtar, Arun Sharma and Sally A. El-Zahaby*
Pan-Cancer Analysis of Histone Methyltransferase KMT2D with Potential Implications for Prognosis and Immunotherapy in Human Cancer
Journal:
Combinatorial Chemistry & High Throughput Screening
Volume:
26
Page:
83-92
Author(s):
Guoning Chen, Peijie Chen, Jianwen Zhou and Guangcheng Luo*